| Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation B Temizoz, K Hioki, S Kobari, N Jounai, T Kusakabe, MSJ Lee, C Coban, ... International Immunology 34 (7), 353-364, 2022 | 13 | 2022 |
| Discovery of Self‐Assembling Small Molecules as Vaccine Adjuvants S Jin, HT Vu, K Hioki, N Noda, H Yoshida, T Shimane, S Ishizuka, ... Angewandte Chemie International Edition 60 (2), 961-969, 2021 | 13 | 2021 |
| Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain K Kobiyama, M Imai, N Jounai, M Nakayama, K Hioki, ... bioRxiv, 2021.03. 04.433852, 2021 | 9 | 2021 |
| 5, 6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation B Temizoz, T Shibahara, K Hioki, T Hayashi, K Kobiyama, MSJ Lee, ... Frontiers in Immunology 15, 1353336, 2024 | 7 | 2024 |
| Machine learning-assisted screening of herbal medicine extracts as vaccine adjuvants K Hioki, T Hayashi, Y Natsume-Kitatani, K Kobiyama, B Temizoz, ... Frontiers in Immunology 13, 847616, 2022 | 7 | 2022 |
| TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model MD Castro Eiro, K Hioki, L Li, MEP Wilmsen, CH Kiernan, ... The Journal of Immunology 212 (3), 455-465, 2024 | 4 | 2024 |
| Identification of a Self-Assembling Small-Molecule Cancer Vaccine Adjuvant with an Improved Toxicity Profile SH Zhuo, N Noda, K Hioki, S Jin, T Hayashi, K Hiraga, H Momose, WH Li, ... Journal of Medicinal Chemistry 66 (18), 13266-13279, 2023 | 1 | 2023 |
